The aggressive nature of triple-negative breast cancer often leaves clinicians with a narrow window for effective intervention due to its lack of hormone receptors and rapid metastatic progression. This specific subtype has historically bypassed traditional targeted therapies, necessitating a
Commercial and academic users alike can access the analysis workspace for free to find genes or generate comprehensive gene list reports for their publications. Modern high-throughput sequencing generates massive datasets that require sophisticated interpretation to uncover underlying biological
The persistent challenge of accurately predicting patient response to neoadjuvant chemotherapy in hormone receptor-positive, HER2-negative breast cancer remains a significant hurdle in the oncology field today. While systemic treatment before surgery aims to shrink tumors and improve surgical
While psoriasis affects approximately 125 million people globally, the medical community increasingly views the condition as a systemic inflammatory disorder rather than just a localized skin disease. This evolving perspective stems from the recognition that the visible, scaly plaques are
The biological hurdles of treating solid tumors with T-cell therapy are being decoded through new findings linking tumor lesion diameters to the ultimate durability of the patient response. At the current Society for Immunotherapy of Cancer Annual Meeting, researchers presented updated data
Engineering T-cells to recognize multiple antigens allows the treatment to remain effective even if some tumor cells stop expressing one of the targeted markers. For families facing a pediatric Diffuse Midline Glioma (DMG) diagnosis, the news is historically grim, as this aggressive cancer